Based on literature data [37,38], we performed IR exposure of Tau P301S mice at the early stage of pathology, behavioral testing at the early symptomatic stage of tauopathy, and a postmortem study of cytokine content at the terminal stage of tauopathy in an effort to avoid natural decline in the livestock groups of mice. This evidence concerns the gene MAPT and tauopathy.